Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $14.61 USD
Change Today +0.325 / 2.28%
Volume 609.6K
FOLD On Other Exchanges
As of 11:58 AM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Pol F. Boudes M.D., Ph.D.

AgeTotal Calculated CompensationThis person is connected to 14 board members in 1 different organizations across 3 different industries.

See Board Relationships


Dr. Pol F. Boudes, M.D., PhD, has been the Chief Medical Officer at Cymabay Therapeutics, Inc. since March 2014. Dr. Boudes served as the Chief Medical Officer of Amicus Therapeutics, Inc. from January 2009 to April 30, 2013. Dr. Boudes served as Head of Medical Development, US and Executive Director, Gynecology & Andrology at Bayer HealthCare Pharmaceuticals (formerly Berlex, Inc.) from 2004 to 2009. Dr. Boudes served as Vice President, Global Clinical Development, ...

Read Full Background

Corporate Headquarters*

1 Cedar Brook Drive
Cranbury, New Jersey 08512

United States

Phone: 609-662-2000
Fax: 609-662-2001

Board Members Memberships*

There is no Board Members Memberships data available.


Université d'Aix-Marseille II
Université d'Aix-Marseille II

Other Affiliations*

Annual Compensation*

Total Annual Compensation$439,000

Stock Options*

All Other Compensation$24,737
Exercisable Options4,333
Unexercisable Options98,667
Total Number of Options103,000

Total Compensation*

Total Annual Cash Compensation$463,737
Total Short Term Compensation$439,000
Other Long Term Compensation$24,737
Total Calculated Compensation$979,585
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FOLD:US $14.61 USD +0.325


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AMICUS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at